Abstract:ABSTRACT Metabolic syndrome (MetS) represents a cluster of major risk factors known to be associated with the development of aging-related diseases, such as cardiovascular disease and diabetes. Telomere length (TL) is often used as a cellular marker for biological age. Shorter TL indicates increased biological age. It is unknown whether maintenance of a short TL could be predictive for onset of metabolic diseases associated with increasing biological age. A number of studies found significant associations between shorter TL and dysregulated MetS components, but other studies did not confirm this finding. This cohort study investigated the relationship between shorter baseline TL and a worse metabolic profile with less favorable trajectories of MetS components over a 6-year follow-up. Participants included 2842 men and women aged 18 to 65 years who were part of The Netherlands Study of Depression and Anxiety, an ongoing prospective cohort study with 6-year follow-up. Telomere length from leukocytes was determined using quantitative polymerase chain reaction. Metabolic syndrome components (waist circumference, triglycerides, high-density lipoprotein &lsqb;HDL&rsqb;, cholesterol, fasting glucose, and systolic and diastolic blood pressure) were determined at baseline and after 2 and 6 years. Adjustments were made at baseline and 2- and 6-year follow-up for covariates (sociodemographic, lifestyle, and health factors) that could affect cross-sectional and longitudinal analyses. Shorter TL was cross-sectionally associated with a higher number of MetS abnormalities (&bgr; = 0.075, SE = 0.023, P = 0.001), higher waist circumference (&bgr; = 0.647, SE = 0.238, P = 0.007), triglycerides (&bgr; = .038, SE = 0.009, P < 0.001), and fasting glucose (&bgr; = 0.011, SE = 0.003, P < 0.001), and with lower HDL cholesterol (&bgr; = − 0.016, SE = 0.008, P = 0.05). No consistent patterns of association between TL and hypertension were found. Baseline differences progressively diminished over time; however, shorter baseline TL was still significantly associated with a worse level for most MetS components at both the 2- or 6-year follow-up. These findings show that cellular aging, as assessed by TL, is associated with a higher number of MetS abnormalities (representing a more severe metabolic risk profile) that persists even after a period of 6 years. The data suggest that a shorter TL could be predictive for the onset of various aging-related somatic diseases through its effect on metabolic alterations.

Telomere Length Is a Driving Hallmark for Aging-Related Biochemical Hallmarks: Evidence From the Shared Genetic Effect and Causal Inference

Phthalates and Phenols, Leukocyte Telomere Length, and Breast Cancer Risk and Mortality in the Long Island Breast Cancer Study Project.

Genetic liability to human serum metabolites is causally linked to telomere length: insights from genome-wide Mendelian randomization and metabolic pathways analysis

Telomere length and aging-related outcomes in humans: A Mendelian randomization study in 261,000 older participants

17-Year Follow-Up of Association Between Telomere Length and All-Cause Mortality, Cardiovascular Mortality in Individuals with Metabolic Syndrome: Results from the NHANES Database Prospective Cohort Study

Associations of genetically predicted circulating levels of cytokines with telomere length: a Mendelian randomization study

Telomere Length as a Marker of Cellular Aging Is Associated With Prevalence and Progression of Metabolic Syndrome

Breaking down causes, consequences, and mediating effects of age-related telomere shortening on human health

The association between telomere length and blood lipids: a bidirectional two-sample Mendelian randomization study

Proteomic Mendelian randomization to identify protein biomarkers of telomere length

Telomere Length as a Marker of Biological Age: State-of-the-Art, Open Issues, and Future Perspectives

Telomere length measurement as a clinical biomarker of aging and disease

Telomere Length is Maternally Inherited and Associated with Lipid Metabolism in Chinese Population.

Epigenome-wide association study of leukocyte telomere length.

Whole exome sequencing analyses reveal novel genes in telomere length and their biomedical implications

DNA Methylation-Based Estimator of Telomere Length

Dynamics of leukocyte telomere length in adults aged 50 and older: a longitudinal population-based cohort study

Abstract 2745: Genetic Determinants of Telomere Length – a Genome Wide Association Study

Unraveling the Causal Genes and Transcriptomic Determinants of Human Telomere Length

Leukocyte Telomere Length, T Cell Composition and Dna Methylation Age

Related risk factors for age-dependent telomere shortening change with age from the perspective of life course